Research Article| Volume 12, ISSUE 2, P119-125, April 1998

Benzodiazepine-induced persisting amnestic disorder: Are older aduls at risk?

  • Deborah D. Sumner
    Address reprint requests to Deborah D. Sumner, MA, MS, ARNP, 6494 92 Place North, Suite 205, Pinellas Park, FL 33782.
    Paradigm Health Services, Inc., Clearwater, FL, USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      Currently there are approximately 31.5 million Americans 65 years and older. This number is expected to reach 39.3 million by 2010. This group represents 12% of the population, however, they use 25% to 40% of the prescription medications, averaging 4.5 medications daily; 75% of them use over-the-counter medications as well. This population has also experienced an increase in the prescription of central nervous system (CNS) medications. Benzodiazepines are the most widely prescribed class of CNS antianxiety/sedative medication. This article examines the use of benzodiazepines in relation to physiological, pharmacokintic, and pharmacodynamic changes of the older adult. The amnestic properties of these drugs in relation to the already decreasing cognitive function of the older adult are explored in relationship to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, criteria for substance-induced persisting amnestic disorder.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Archives of Psychiatric Nursing
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Psychiatric Association
        4th ed. Diagnostic and statistical manual of mental disorders. Author, New York1994
        • Ballenger J.C.
        in: Schatzberg A.F. Nemeroff C.B. Textbook of Psychopharmacology. American Psychiatric Press, Inc., Washington, DC1995: 215-230
        • Boss B.J.
        Memory impairments: Forgetfulness versus amnesia.
        Journal of Neuroscience Nursing. 1988; 20: 151-158
        • Conn V.
        • Taylor S.
        • Miller R.
        Cognitive impairment and medication adherence.
        Journal of Gerontological Nursing. 1994; 20: 41-47
        • Curran H.V.
        • Schiwy W.
        • Lader M.
        Differential amnestic properties of benzodiazepines: A dose response comparison of two drugs with similar elimination half-lives.
        Pharmacology. 1987; 92: 358-364
        • Dellasega C.
        • Stricklin M.L.
        Use of central nervous system medications among elderly home health clients.
        Applied Nursing Research. 1996; 9: 130-135
        • DeMaagd G.
        High-risk drugs in the elderly population.
        Geriatric Nursing. 1995; 16: 198-207
        • Greenblatt D.J.
        • Miller L.G.
        • Shader R.I.
        Neurochemical and pharmacokinetic correlates of the clinical action of benzodiazepine hypnotic drugs.
        The American Journal of Medicine. 1990; 88: 3A-18S
        • Hanninen T.
        • Reinikinen K.J.
        • Helkala E.L.
        • Koivisto K.
        • Mykkanen L.
        • Laakso M.
        • Pyorala K.
        • Riekkinen P.J.
        Subjective memory complaints and personality traits in normal elderly subjects.
        Journal of the American Geriatric Society. 1994; 42: 1-4
        • Hindmarch I.
        • Sherwood N.
        • Kerr J.S.
        Amnestic effects of triazolam and other hypnotics.
        Progress in Neuro-Psychopharmacological and Biological Psychiatry. 1993; 17: 407-413
        • Jutagir R.
        Psychological aspects of aging: When does memory loss signal dementia?.
        Geriatrics. 1994; 49: 45-52
        • Kaplan H.I.
        • Sadock B.J.
        2nd ed. Pocket Handbook of Psychiatric Drug Treatment. Williams & Wilkins, Washington, DC1996: 49-56
        • Kaplan H.I.
        • Sadock B.J.
        • Grebb J.A.
        Synopsis of psychiatry: Behavioral sciences clinical psychiatry. 7th ed. Williams & Wilkins, Baltimore, MD1994: 357-361
        • Kral V.A.
        Neuropsychiatric observations in an old people's home.
        Journal of Gerontology. 1958; 13: 169-176
        • Kumar R.
        • Mac D.S.
        • Gabrielli W.F.
        • Goodwin D.W.
        Anxiolytics and memory: A comparison of lorazepam and alprazolam.
        Journal of Clinical Psychiatry. 1987; 48: 158-160
        • LeSage J.
        Polypharmacy in geriatric patients.
        Nursing Clinics of North America. 1991; 26: 273-287
        • Maxmen J.S.
        • Ward N.G.
        Antianxiety Agents.
        in: Psychotropic Drugs Fast Facts. 2nd ed. W.W. Norton & Company, Inc., Baltimore, MD1995: 255-312
        • Mejo S.L.
        Anterograde amnesia linked to benzodiazepines.
        Nurse Practitioner. 1992; 17: 44
        • Mejo S.L.
        Anterograde amnesia linked to benzodiazepines.
        Nurse Practitioner. 1992; 17: 49-50
        • Palmieri D.T.
        Clearing up the confusion: Adverse effects of medications in the elderly.
        Journal of Gerontological Nursing. 1991; 17: 32-35
        • Polster M.R.
        Drug-induced amnesia: Implications for cognitive neuropsychological investigation of memory.
        Psychological Bulletin. 1993; 114: 477-493
        • Rothschild A.J.
        Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: A review of the literature.
        Journal of Clinical Psychiatry. 1992; 53: 69-79
        • Rusted J.M.
        • Eaton-Williams P.
        • Warburton D.M.
        A comparison of the effects of scopolamine and diazepam on working memory.
        Psychopharmacology. 1991; 105: 442-445
        • Scharf M.B.
        • Fletcher K.
        • Graham J.P.
        Comparative amnestic effects of benzodiazepine hypnotic agents.
        Journal of Clinical Psychiatry. 1988; 49: 134-137
        • Vgontzas A.N.
        • Kales A.
        • Bixler E.O.
        Benzodiazepine side effects: Role of pharmacokinetics and pharmacodynamics.
        Pharmacology. 1995; 51: 205-223
        • Vogel G.
        Clinical uses and advantages of low doses of benzodiazepine hypnotics.
        Journal of Clinical Psychiatry. 1992; 53: 19-23